Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023
Lloyd Price
NOVEMBER 25, 2023
These multiples are down from the levels seen in 2022, but they are still higher than the average EV to sales multiple for all industries. The most active subsectors for DTx M&A deals are mental health, oncology, and diabetes. EV to EBITDA: 12.5x The average deal size for DTx M&A deals is increasing.
Let's personalize your content